CBLI insider filings
Cytocom, Inc. — 6 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2021-08-04. Screen CBLI transaction legs live →
Insider transaction summary — last 90 days
No insider filings (Forms 3/4/5) for CBLI between 2026-08-23 and 2026-11-21. The table below lists the most recent filings on record.
Recent insider filings — Cytocom, Inc.
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2021-08-04 | 4 | Handley Michael K — President and CEO, Director | Grant/award (A): 296,609 @ $0 | EDGAR |
| 2021-07-29 | 4 | Buckheit Robert — Chief Technology Officer | Grant/award (A): 24,378 @ $0 | EDGAR |
| 2021-07-29 | 4 | Selsky Clifford — Chief Medical Officer | Grant/award (A): 101,579 @ $0 | EDGAR |
| 2021-07-29 | 4 | McAvoy Cozette M. — Chief Legal Officer | Grant/award (A): 60,947 @ $0 | EDGAR |
| 2021-07-29 | 4 | ARONSTAM PETER — Chief Financial Officer | Grant/award (A): 141,370 @ $0 | EDGAR |
| 2021-07-23 | 4 | Miller Langdon L — Chief Medical Officer | Option exercise (M): 10,000 @ $3 · Option exercise (M): 10,000 (derivative) @ $0 | EDGAR |
Recent 8-K events — Cytocom, Inc.
Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2023-02-01 | 8-K | 3.03 — Material Modification to Rights of Security Holders 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 9.01 — Financial Statements and Exhibits | EDGAR |
| 2023-01-20 | 8-K | 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing 9.01 — Financial Statements and Exhibits | EDGAR |
| 2022-11-15 | 8-K | 1.01 — Entry into a Material Definitive Agreement 2.03 — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant 3.02 — Unregistered Sales of Equity Securities 9.01 — Financial Statements and Exhibits | EDGAR |
| 2022-11-07 | 8-K | 1.01 — Entry into a Material Definitive Agreement 3.02 — Unregistered Sales of Equity Securities 9.01 — Financial Statements and Exhibits | EDGAR |
| 2022-10-27 | 8-K | 8.01 — Other Events | EDGAR |
| 2022-10-24 | 8-K | 1.01 — Entry into a Material Definitive Agreement 2.03 — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant 3.02 — Unregistered Sales of Equity Securities 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2022-10-17 | 8-K | 1.01 — Entry into a Material Definitive Agreement 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing 9.01 — Financial Statements and Exhibits | EDGAR |
| 2022-09-27 | 8-K | 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing | EDGAR |
| 2022-09-23 | 8-K/A | 4.01 — Changes in Registrant's Certifying Accountant 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2022-09-09 | 8-K | 1.01 — Entry into a Material Definitive Agreement 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing 3.02 — Unregistered Sales of Equity Securities 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=CBLI returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs